Literature DB >> 18154194

Prescribing methadone for pain management in end-of-life care.

John F Manfredonia1.   

Abstract

Methadone hydrochloride is an effective, inexpensive, and relatively safe opioid to use in the treatment of patients with chronic pain. It is especially effective in management of pain during the final stages of life, as it is the only long-acting analgesic available in liquid form. However, because methadone has a long half-life, individual wide variations, and potential for accumulation and overdosage, physicians must judiciously and conscientiously prescribe it. Also, they should closely monitor patients during the titration phase and educate them with regard to basic pharmacologic properties and potential side effects. A plan to start at low doses and proceed slowly is applicable to methadone.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 18154194

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  4 in total

1.  Establishing the feasibility of measuring performance in use of addiction pharmacotherapy.

Authors:  Cindy Parks Thomas; Deborah W Garnick; Constance M Horgan; Kay Miller; Alex H S Harris; Melissa M Rosen
Journal:  J Subst Abuse Treat       Date:  2013-03-13

2.  Associations of Maternal Prenatal Drug Abuse With Measures of Newborn Brain Structure, Tissue Organization, and Metabolite Concentrations.

Authors:  Bradley S Peterson; Tove Rosen; Sherry Dingman; Zachary R Toth; Siddhant Sawardekar; Xuejun Hao; Feng Liu; Dongrong Xu; Zhengchao Dong; Jarod B Peterson; Ji Hoon Ryoo; Dana Serino; Craig A Branch; Ravi Bansal
Journal:  JAMA Pediatr       Date:  2020-09-01       Impact factor: 16.193

3.  A single-institution, randomized, pilot study evaluating the efficacy of gabapentin and methadone for patients undergoing chemoradiation for head and neck squamous cell cancer.

Authors:  Gregory M Hermann; Austin J Iovoli; Alexis J Platek; Chong Wang; Austin Miller; Kristopher Attwood; Daniel J Bourgeois; Anurag K Singh
Journal:  Cancer       Date:  2019-12-23       Impact factor: 6.921

Review 4.  Narrative review of the management of oral mucositis during chemoradiation for head and neck cancer.

Authors:  Lauren F Judge; Mark K Farrugia; Anurag K Singh
Journal:  Ann Transl Med       Date:  2021-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.